dysbiosis index GA-map
Selected indexed studies
- A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups. (Clin Exp Gastroenterol, 2024) [PMID:38646157]
- Assessment of the Gut Microbiome in Patients with Coexisting Irritable Bowel Syndrome and Chronic Fatigue Syndrome. (Nutrients, 2025) [PMID:40647335]
- Separating "good" from "bad" faecal dysbiosis - evidence from two cross-sectional studies. (BMC Obes, 2018) [PMID:30524735]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups. (2024) pubmed
- Assessment of the Gut Microbiome in Patients with Coexisting Irritable Bowel Syndrome and Chronic Fatigue Syndrome. (2025) pubmed
- Separating "good" from "bad" faecal dysbiosis - evidence from two cross-sectional studies. (2018) pubmed
- Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. (2024) pubmed
- Multi-Strain Probiotic Improves Tryptophan Metabolism and Symptoms in Chronic Fatigue Syndrome Patients with Co-Occurring Irritable Bowel Syndrome: An Open-Label Pilot Study. (2026) pubmed
- Assessment of Urinary Dopamine and Serotonin Metabolites in Relation to Dysbiosis Indicators in Patients with Functional Constipation. (2024) pubmed
- Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls. (2024) pubmed
- Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity. (2017) pubmed
- Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. (2015) pubmed
- Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character). (2020) pubmed